Journals / Diagnostic and Interventional Radiology / 2022 / Cilt: 28 - Sayı: 1

Proton density fat fraction: magnetic resonance imaging applications beyond the liver

Pages
83–91
Publication Date
2022-10-11
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Future studies can enable tracking of quantitative fat fraction changes in different organs simultaneously, which can be critical in understanding the fat metabolism.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Magnetic resonance imaging-proton density fat fraction (MRI-PDFF) is an emerging quantitative imaging biomarker that accurately measures the fat fraction of tissue by correcting factors influencing magnetic resonance signal intensity.
📊
Key Findings & Data:Beyond fat quantification, it also measures R2* which is a direct measure of iron concentration.
💡
Conclusion & Impact:Future studies can enable tracking of quantitative fat fraction changes in different organs simultaneously, which can be critical in understanding the fat metabolism.
🔬Design:Review & Systematic Survey
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Magnetic resonance imaging-proton density fat fraction (MRI-PDFF) is an emerging quantitative imaging biomarker that accurately measures the fat fraction of tissue by correcting factors influencing magnetic resonance signal intensity. Beyond fat quantification, it also measures R2* which is a direct measure of iron concentration. The utilization of MRI-PDFF in liver diseases is well established. In the present review, we focused on applications of MRI-PDFF in different body areas including pancreas, bone, muscle, spleen, testis, visceral, and subcutaneous adipose tissue. Future studies can enable tracking of quantitative fat fraction changes in different organs simultaneously, which can be critical in understanding the fat metabolism.

🔖

Cite This Article

AKATA, D., İDİLMAN, İ. S., KARAOSMANOĞLU, A. D., YILDIZ, A. E., ÖZMEN, M. N., KARCAALTINÇABA, M. (2022). Proton density fat fraction: magnetic resonance imaging applications beyond the liver. Diagnostic and Interventional Radiology, Cilt: 28 - Sayı: 1, 83–91. https://ajindex.com/articles/487255

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (11)

  1. Yokoo T, Bydder M, Hamilton G, et al. Nonalcoholic fatty liver disease: diagnostic and fat-grading accuracy of low-flip-angle multiecho gradient-recalled-echo MR imaging at 1.5 T. Radiology. 2009
  2. 251(1):67-76. [Crossref] 2. Reeder SB, Robson PM, Yu H, et al. Quantification of hepatic steatosis with MRI: the effects of accurate fat spectral modeling. J Magn Reson Imaging. 2009
  3. 29(6):1332-1339. [Crossref] 3. Reeder SB, Cruite I, Hamilton G, Sirlin CB. Quantitative assessment of liver fat with magnetic resonance imaging and spectroscopy. J Magn Reson Imaging. 2011
  4. 34(4):729-749. [Crossref] 4. Permutt Z, Le TA, Peterson MR, Seki E, Brenner DA, Sirlin C, Loomba R. Correlation between liver histology and novel magnetic resonance imaging in adult patients with non-alcoholic fatty liver disease - MRI accurately quantifies hepatic steatosis in NAFLD. Aliment Pharmacol Ther. 2012
  5. 36(1):22-29. [Crossref] 5. Tang A, Tan J, Sun M, Hamilton G, Bydder M, Wolfson T, Gamst AC, Middleton M, Brunt EM, Loomba R, Lavine JE, Schwimmer JB, Sirlin CB. Nonalcoholic fatty liver disease: MR imaging of liver proton density fat fraction to assess hepatic steatosis. Radiology. 2013
  6. 267(2):422-431. [Crossref] 6. Idilman IS, Aniktar H, Idilman R, et al. Hepatic steatosis: quantification by proton density fat fraction with MR imaging versus liver biopsy. Radiology. 2013
  7. 267(3):767-775. [Crossref] 7. Idilman IS, Keskin O, Elhan AH, Idilman R, Karcaaltincaba M. Impact of sequential proton density fat fraction for quantification of hepatic steatosis in nonalcoholic fatty liver disease. Scand J Gastroenterol. 2014
  8. 49(5):617-624. [Crossref] 8. Ajmera V, Park CC, Caussy C, et al. Magnetic resonance imaging proton density fat fraction associates with progression of fibrosis in patients with nonalcoholic fatty liver disease. Gastroenterology. 2018
  9. 155(2):307-310.e2. [Crossref] 9. Caussy C, Reeder SB, Sirlin CB, Loomba R. Noninvasive, quantitative assessment of liver fat by MRI-PDFF as an endpoint in NASH trials. Hepatology. 2018
  10. 68(2):763-772. [Crossref] 10. Schawkat K, Eshmuminov D, Lenggenhager D, et al. Preoperative evaluation of pancreatic fibrosis and lipomatosis: correlation of magnetic resonance findings with histology using magnetization transfer imaging and multigradient echo magnetic resonance imaging. Invest Radiol. 2018
  11. 53(12):720-727. [Crossref] 11. Idilman IS, Tuzun A, Savas B, et al. Quantification of liver, pancreas, kidney, and vertebral body MRI-PDFF in non-alcoholic fatty li